RecruitingPhase 4NCT04771728

A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis

Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital


Sponsor

Peking University Shenzhen Hospital

Enrollment

140 participants

Start Date

Feb 1, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators are trying to determine if oral Probiotics(Umeta-mimi,30 days) with Metronidazole vaginal suppositories (7 days) is better than using Metronidazole vaginal suppositories(7 days) only in preventing the recurrence of bacterial vaginosis


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Metronidazole vaginal suppositories and a drug called Metronidazole vaginal suppositories and Probiotics(Umeta-mimi) for people with bacterial vaginosis. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMetronidazole vaginal suppositories

Metronidazole vaginal suppositories (200 mg,2 capsules per day,7 days )

DRUGMetronidazole vaginal suppositories and Probiotics(Umeta-mimi)

Metronidazole vaginal suppositories (200 mg,2 capsules per day,7 days ) and Oral pobiotics(Umeta-mimi,5×109cfu per day,30 days)


Locations(1)

Peking University Shenzhen Hosptal

Shenzhen, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04771728


Related Trials